Irodalom:
1. Thomas L. Germs. N Engl J Med 1972; 287: 553-555.
2. Rinderknecht H. Genetic determinants of mortality in acute necrotizing pancreatitis. Int J Pancreatol
1994; 16: 11-15.
3. Henson PM. Dampening inflammation. Nature Immunol 2005; 6 (12): 1179-1181.
4. Yadav D, Loewenfels AB. Trends in the epidemiology of the first attack of acute pancreatitis. Pancreas
2006; 33: 323-330.
5. Martinez J, Johnson CC, Sanchez-Paya J et al. Obesity is a definitive risk factor of severity and mortality
in acute pancreatitis: An updated meta-analysis. Pancreatology 2006; 6: 206-209.
6. Papachristou GI, Papachristou DJ, Avula H et al. Obesity increases the severity of acute pancreatitis:
Performance of APACHE-O score and correlation with the inflammatory response. Pancreatology
2006; 6: 279-285.
7. De Waele B, Vanmierlo B, Nieuwenhove YV et al: Impact of body weight and class I, II and III obesity
on the outcome of acute biliary pancreatitis. Pancreas 2006; 32 (4): 343-345.
8. Tilg H, Moschen AR: Adipocytokines: mediators linking adipose tissue, inflammation and immunity.
Nature Reviews/ Immunology 2006; 6: 772-783.
9. Blum A, Tatour I, Monir M et al. Gallstones in pregnancy and their complications: Postpartum acute
pancreatitis and acute peritonitis. Eur J Intern Med 2005; 16: 473-476.
10. Ko C. Biliary sludge and acute pancreatitis during pregnancy. Nat Clin Pract Gastroenterol Hepatol.
2006; 3: 53-57.
11. Robertson KW, Stewart IS, Imrie CW. Severe acute pancreatitis and pregnancy. Pancreatology 2006; 6:
309-315.
378 Gastro Update 2007
12. Boakye MK, Macfoy D, Rice C. Alcoholic pancreatitis in pregnancy. J Obstet Gynaecol. 2006; 26: 815-7.
13. Abu Musa AA, Usta IM, Rechdan JB et al. Recurrent hypertriglyceridemia-induced pancreatitis in pregnancy:
a management dilemma. Pancreas. 2006; 32: 227-8.
14. Hofner P, Balog A, Gyulai Z et al. Polymorphism in the IL-8 gene, but not in the TLR4 gene increases
the severity of acute pancreatitis. Pancreatology 2006; 6: 542-548.
15. Scott AM, Saleh M: The inflammatory caspases: guardians against infection and sepsis. Cell Death
Differentiation 2007; 14: 23-31.
16. Koussoulas V, Tzivras M, Karagianni V et al. Monocytes is systemic inflammatory syndrome:
Differences between sepsis and acute pancreatitis. World J Gastroenterol 2006; 12 (41): 6711-6714.
17. Guzman EA, Rudnicki M. Intricacies of host response in acute pancreatitis. J Am Coll Surg 2006; 202:509-519.
18. Rajaratnam SG, Martin IG. Admission serum glucose level: An accurate predictor of outcome in gallstone
pancreatitis. Pancreas 2006; 33: 27-30.
19. Bagul A, Pushpakom S, Boylan J et al. Quantitative analysis of plasma DNA in severe acute pancreatitis.
JOP J Pancreas 2006; 7: 602-607.
20. Spitzer AL, Barcia AM, Schell MT et al. Applying Ockham’s razor to pancreatitis prognostication. Ann
Surg 2006; 243: 380-388.
21. Whitcomb DC. Acute pancreatitis. N Engl J Med 2006; 354: 2142-50.
22. Heinrich S, Schafer M, Rousson V et al. Evidence-based treatment of acute pancreatitis. A look of established
paradigms. Ann Surg 2006; 243: 154-168.
23. Pezzilli R, Fantini L, Morselli-Labate AM. New approaches for the treatment of acute pancreatitis. JOP
J Pancreas 2006; 7: 79-91.
24. Niederau C, Hippenstiel J. Conservative management of acute pancreatitis: Complications and outcome
in a community-based hospital. Pancreas 2006; 32: 67-79.
25. Runzi M, Layer P, Buchler MW et al. The therapy of acute pancreatitis. General guidelines. Working
group of the Society for Scientific-Medical Specialities. Z Gastroenterol 2000; 38; 571-581.
26. Isenmann R, Rünzi M, Kron M et al. Prophylactic antibiotic treatment in patients with predicted severe
acute pancreatitis: a placebo-controlled, double blind trial. Gastroenterology 2004; 126: 997-1004.
27. Mazaki T, Ishii Y, Takayama T. Meta-analysis of prophylactic antibiotic use in acute necrotizing
pancreatitis. Br J Surg 2006; 93: 674-684.
28. Eatock FC, Chong P, Menezes N et al. A randomized study of early nasogastric versus nasojejunal
feeding in severe acute pancreatitis. Am J Gastroenterol 2005; 100: 432-439.
29. Eckerwall GE, Axelsson JB, Andersson RG. Early nasogastric feeding in predicted severe acute pancreatitis:
A clinical, randomized study. Ann Surg 2006, 244: 959-967.
30. Modena JT, Cavasco LB, Basto CA et al. Total enteral nutrition as prophylactic therapy for pancreatic
necrosis infection in severe acute pancreatitis. Pancreatology 2006; 6: 58-64.
31. Muftuoglu MAT, Isikgor S, Tosun S et al. Effects of probiotics on the severity of experimental acute
pancreatitis. Eur J Clin Nutr 2006; 60: 464-468.
32. Pezzilli R, Frantini LP. Probiotics and severe acute pancreatitis. JOP. 2006; 11: 92-3.
33. Farkas G, Marton J, Mandi Y et al. Surgical management and complex treatment of infected pancreatic
necrosis: 18-year experience at a single center. J Gastrointest Surg 2006; 10: 278-85.
34. Omary MB, Lugea A, Lowe AW et al. The pancreatic stellate cell: a star on the rise in pancreatic diseases.
J Clin Invest 2007; 117: 50-59.
35. Glass A, Math MS, Kundt G et al. Delayed response toward activation in pancreatic stellate cells.
Pancreas 2006; 33: 293-300.
36. Wang JL, Hu R, Lugea A. et al Ethanol feeding alters death signaling in the pancreas. Pancreas 2006;
32: 351-59.
A hasnyálmirigy 379
37. Whitcomb DC, Gorry MC, Preston RA et al. Hereditary pancreatitisis caused by mutation in the cationic
trypsinogen gene. Nat Genet 1996; 14: 141-145.
38. Schmid RM, Whitcomb DC. Genetically modified models of chronic pancreatitis. Gastroenterol 2006;
131: 2012-14.
39. Archer H, Jura N, Keller J et al. A mouse model of hereditary pancreatitis generated by transgenic
expression of R122H trypsinogen. Gastroenterol 2006; 131: 1844-55.
40. Witt H, Sahin-Toth M, Landt O et al. A degradation-sensitive anionic trypsinogen (PRSS2) variant protects
against chronic pancreatitis. Nat Genet 2006; 38: 668-73.
41. Keiles S, Kammesheidt A. Identification of CFTR, PRSS1 and SPINK1 mutations in 381 patients with
pancreatitis. Pancreas 2006; 33: 221-227.
42. Sahin-Tóth M. Biochemical models of hereditary pancreatitis. Endocrinol Metab Clin N Am 2006; 35:
303-12.
43. Stevens T, Conwell DL, Zuccaro G. et al. A randomized crossover study of secretin-stimulated endo
scopic and Dreiling tube pancreatic function test methods in healthy subjects. Am J Gastroenterol 2006;
101: 351-55.
44. Yadav D, Chari S. The endoscopic pancreatic exocrine function test (ePFT): can it be the new “gold
standard”? Gastroenterol 2006; 131: 1349-50.
45. Erturk SM, Ichikawa T, Motosugi U et al. Diffusion-weighted MR imaging in the evaluation of pan
creatic exocrine function before and after secretin stimulation. Am J Gastroenterol 2006; 101: 133-36.
46. Chari S, Takahashi N. Drinker’s pancreas and abnormal diffusion-weighted MR: what,s the connection.
Gastroenterol 2006; 131: 676-78.
47. Bagul A, Siriwardena K. Evaluation of the Manchester classification system for chronic pancreatitis.
JOP. J Pancreas 2006; 7: 390-96.
48. Talukdar R, Saikia N, Singal DK et al. Chronic pancreatitis: Evolving paradigms. Pancreatology 2006;
6: 440-49.
49. Sadfi M, Bekal PK, Martin S et al. The effect of oral pancreatic enzymes (Creon 10 capsule) on steatorrea.
Pancreas 2006; 33: 156-162.
50. DiMagno MJ, DiMagno EP. Chronic pancreatitis. Curr Opin Gastroenterol 2006; 22: 487-97.
51. Forsmark CE. Chronic pacreatitis and quality of life. Dig Liver Dis 2006; 38: 116-118.
